Virus News and Research

Latest Virus News and Research

Clonality and magnitude of SARS-CoV-2-reactive CD4+ T cells in COVID-19 convalescent patients after vaccination

Clonality and magnitude of SARS-CoV-2-reactive CD4+ T cells in COVID-19 convalescent patients after vaccination

Researchers identify cellular serpins as host factors that restrict SARS-CoV-2 infection

Researchers identify cellular serpins as host factors that restrict SARS-CoV-2 infection

Study finds recent influenza vaccination is associated with an appreciable reduction in the risk of SARS-CoV-2 infection and COVID-19 severity

Study finds recent influenza vaccination is associated with an appreciable reduction in the risk of SARS-CoV-2 infection and COVID-19 severity

Study projects the COVID-19 burden caused by Omicron infections in mainland China should the zero-COVID policy be lifted

Study projects the COVID-19 burden caused by Omicron infections in mainland China should the zero-COVID policy be lifted

Delta- and Omicron BA.1-variant specificity of B cell repertoires established by an initial Wuhan strain infection

Delta- and Omicron BA.1-variant specificity of B cell repertoires established by an initial Wuhan strain infection

Imprinted antibody responses towards SARS-CoV-2 Omicron subvariants

Imprinted antibody responses towards SARS-CoV-2 Omicron subvariants

Study shows reduced respiratory syncytial virus antibody levels in women of childbearing age and infants during the COVID-19 pandemic

Study shows reduced respiratory syncytial virus antibody levels in women of childbearing age and infants during the COVID-19 pandemic

Research looks at potential of pantethine against SARS-CoV-2

Research looks at potential of pantethine against SARS-CoV-2

SARS-CoV-2 Omicron escapes immune response due to high ACE2 affinity and low antibody specificity

SARS-CoV-2 Omicron escapes immune response due to high ACE2 affinity and low antibody specificity

Antifungal agent Bifonazole as an antiviral against SARS-CoV-2

Antifungal agent Bifonazole as an antiviral against SARS-CoV-2

The promise of RNA medicine is targeted and personalized

The promise of RNA medicine is targeted and personalized

MRC/UVRI and LSHTM Uganda Research Unit launches new state-of-the-art clinical research facility

MRC/UVRI and LSHTM Uganda Research Unit launches new state-of-the-art clinical research facility

Inexpensive daily diet supplementation in pregnancy can reduce complications at birth, study shows

Inexpensive daily diet supplementation in pregnancy can reduce complications at birth, study shows

Discovery of host co-factors necessary for SARS-CoV2 infection

Discovery of host co-factors necessary for SARS-CoV2 infection

UC Davis researchers identify a protein that keeps Kaposi's sarcoma-associated herpesvirus dormant

UC Davis researchers identify a protein that keeps Kaposi's sarcoma-associated herpesvirus dormant

Direct influenza infection of the heart drives cardiac complications, study reveals

Direct influenza infection of the heart drives cardiac complications, study reveals

First oral antiviral approved for early treatment of COVID-19

First oral antiviral approved for early treatment of COVID-19

Study shows efficacy of COVID-19 vaccine in people receiving cancer treatment

Study shows efficacy of COVID-19 vaccine in people receiving cancer treatment

Unique binding property may explain the ability of delta variant to spread more rapidly

Unique binding property may explain the ability of delta variant to spread more rapidly

Review portrays clinical journey of messenger RNA vaccines and mRNA-based therapies

Review portrays clinical journey of messenger RNA vaccines and mRNA-based therapies

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.